Table 4.

Proportion of the phenotypic variance explained by the markers significantly associated with the evaluated traits

Trait1	Family	LG	Method2 and QTL position (cM)	Marker3	Marker position (cM)4	R2 (%)
Re	FamAS-2	4	LR: 0/ML: 10	Sma-USC47	0.00	7.4
	FamAS-3	6	LR: 0/ML: 26	Sma-USC147	4.52	16.2
	FamAP	5	ML: 21	SmaUSC-E30	0.00	8.9
		9	LR: 31/ML: 38	SmaUSC-E23	30.75	10.5
				SmaUSC-E41	45.68	12.4
				Sma-USC21	53.91	11.6
		16	ML: 35	Sma-USC256	32.75	13.6
Su	FamAS-2	4	LR: 0/ML: 10	Sma-USC47	0.00	8.1
		11	LR: 43	Sma-USC158	23.39	10.1
	FamAS-3	6	LR: 0/ML: 26	Sma-USC147	4.52	16.8
	FamAP	5	ML: 19	SmaUSC-E30	0.00	8.9
		9	LR: 31/ML: 36	SmaUSC-E23	30.75	12.3
				SmaUSC-E41	45.68	12.8
				Sma-USC21	53.91	12.0
		16	ML: 36	Sma-USC256	32.75	12.4

¹Re: resistance; Su: survival.

LG: linkage group.

²LR: linear regression method; ML: maximum likelihood method;

³BLAST annotation [17] was only recorded for Sma-USC23 (3-Hydroxibutirate dehydrogenase type 2) and Sma-USC41 (Helicase with zinc finger domain).

⁴Marker position in centimorgan (cM) within the genetic map by Bouza et al. [17].

R² (%): proportion of the explained phenotypic variance.